Consensus Northwest Biotherapeutics, Inc. Börse Stuttgart
Stocks
NBYB
US66737P6007
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1800 EUR | 0.00% |
|
+36.36% | -12.62% |
Evolution of the Average Target: Northwest Biotherapeutics, Inc.
Evolution of the Target Price: Northwest Biotherapeutics, Inc.
Changes in Analyst Recommendations: Northwest Biotherapeutics, Inc.
74136f9703cc4ae69502a99d.d45mPlXjExek-iMHNccTjPASnnkTMCu7WQ_wf53Z-HI.QtsHDjiuVC_xsBtzXopZvMFQ9xAmfW7oLzbAPPmYokI15Dx4Ybd9Wv3KFw~3bee7c67d2eceeb76c5cffaa067c0dd5
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +9.67% | |||||
| +17.12% | |||||
| +48.46% | |||||
| +2.01% | |||||
| +29.88% | |||||
| +20.68% | |||||
| -19.3% | |||||
| +7.31% | |||||
| -0.04% | |||||
| Average | +12.86% | |||||
| Weighted average by Cap. | +14.84% |
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1860USD
Average target price
1.000USD
Spread / Average Target
+437.63%
High Price Target
1.000USD
Spread / Highest target
+437.63%
Low Price Target
1.000USD
Spread / Lowest Target
+437.63%
Analyst Consensus Detail
Consensus revision (last 18 months)
SellBuy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1860USD
Average target price
1.000USD
Spread / Average Target
+437.63%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
- NBYB Stock
- Consensus Northwest Biotherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
